Third National Biobank for Population-based Seroprevalence Studies in the Netherlands, Including the Caribbean Netherlands

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2019 May 30

PMID 31138148

Citations 34

Authors

Janneke Doortje Maria Verberk

Regnerus Albertus Vos

Liesbeth Mollema

Jeffrey van Vliet

Joanna Wilhelmina Maria van Weert

Hester Ellen de Melker

Fiona Regina Maria van der Klis

Affiliations

Soon will be listed here.

Abstract

Background: This paper outlines the methodology, study population and response rate of a third large Dutch population-based cross-sectional serosurvey carried-out in 2016/2017, primarily aiming to obtain insight into age-specific seroprevalence of vaccine-preventable diseases to evaluate the National Immunization Programme (NIP). In addition, Caribbean Netherlands (CN) was included, which enables additional research into tropical pathogens.

Methods: A two-stage cluster sampling technique was used to draw a sample of Dutch residents (0-89 years) (NS), including an oversampling of non-Western migrants, persons living in low vaccination coverage (LVC) areas, and an extra sample of persons born in Suriname, Aruba and the former Dutch Antilles (SAN). A separate sample was drawn for each Caribbean island. At the consultation hours, questionnaires, blood samples, oro- and nasopharyngeal swabs, faeces, - and only in the Netherlands (NL) saliva and a diary about contact patterns - were obtained from participants. Vaccination- and medical history was retrieved, and in CN anthropometric measurements were taken.

Results: In total, blood samples and questionnaires were collected from 9415 persons: 5745 (14.4%) in the NS (including the non-Western migrants), 1354 (19.8%) in LVC areas, 501 (6.9%) SAN, and 1815 (23.4%) in CN.

Conclusions: This study will give insight into protection of the population against infectious diseases included in the NIP. Research based on this large biobank will contribute to public health (policy) in NL and CN, e.g., regarding outbreak management and emerging pathogens. Further, we will be able to extend our knowledge on infectious diseases and its changing dynamics by linking serological data to results from additional materials collected, environmental- and pharmacological data.

Citing Articles

Twenty Years of Lyme Borreliosis in the Netherlands: Temporal Trends in Seroprevalence and Risk Factors.

Hoeve-Bakker B, Berg O, Doppenberg H, van der Klis F, van den Wijngaard C, Kluytmans J Microorganisms. 2024; 12(11).

PMID: 39597574 PMC: 11596635. DOI: 10.3390/microorganisms12112185.

Contact behaviour before, during and after the COVID-19 pandemic in the Netherlands: evidence from contact surveys, 2016 to 2017 and 2020 to 2023.

Backer J, Vos E, Den Hartog G, van Hagen C, de Melker H, van der Klis F Euro Surveill. 2024; 29(43).

PMID: 39450517 PMC: 11513762. DOI: 10.2807/1560-7917.ES.2024.29.43.2400143.

SARS-CoV-2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era: Input for Future Response.

Vos E, van Hagen C, Wong D, Smits G, Kuijer M, Wijmenga-Monsuur A Influenza Other Respir Viruses. 2024; 18(6):e13312.

PMID: 38837866 PMC: 11150416. DOI: 10.1111/irv.13312.

Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022.

Van der Heyden J, Leclercq V, Duysburgh E, Cornelissen L, Desombere I, Roukaerts I Arch Public Health. 2024; 82(1):72.

PMID: 38750563 PMC: 11094959. DOI: 10.1186/s13690-024-01298-1.

van Hagen C, Huiberts A, Mutubuki E, de Melker H, Vos E, van de Wijgert J PLoS One. 2024; 19(3):e0300324.

PMID: 38498510 PMC: 10947685. DOI: 10.1371/journal.pone.0300324.

References

Chapman B, Burt M, Frampton C, Collett J, Yeo K, Wilkinson I . The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community. N Z Med J. 2000; 113(1118):394-6. View

Kelly H, Riddell M, Gidding H, Nolan T, Gilbert G . A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine. 2002; 20(25-26):3130-6. DOI: 10.1016/s0264-410x(02)00255-4. View

de Melker H, van den Hof S, Berbers G, Conyn-Van Spaendonck M . Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b. Vaccine. 2003; 21(7-8):716-20. DOI: 10.1016/s0264-410x(02)00587-x. View

van der Klis F, Mollema L, Berbers G, de Melker H, Coutinho R . Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med. 2009; 67(7):301-8. View

de Voer R, Mollema L, Schepp R, De Greeff S, van Gageldonk P, de Melker H . Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine. PLoS One. 2010; 5(8):e12144. PMC: 2921331. DOI: 10.1371/journal.pone.0012144. View

Steens A, Mollema L, Berbers G, van Gageldonk P, van der Klis F, de Melker H . High tetanus antitoxin antibody concentrations in the Netherlands: a seroepidemiological study. Vaccine. 2010; 28(49):7803-9. DOI: 10.1016/j.vaccine.2010.09.036. View

Eeftens M, Beelen R, de Hoogh K, Bellander T, Cesaroni G, Cirach M . Development of Land Use Regression models for PM(2.5), PM(2.5) absorbance, PM(10) and PM(coarse) in 20 European study areas; results of the ESCAPE project. Environ Sci Technol. 2012; 46(20):11195-205. DOI: 10.1021/es301948k. View

Waaijenborg S, Hahne S, Mollema L, Smits G, Berbers G, van der Klis F . Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013; 208(1):10-6. PMC: 4043230. DOI: 10.1093/infdis/jit143. View

Sane J, Gouma S, Koopmans M, de Melker H, Swaan C, van Binnendijk R . Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012. Emerg Infect Dis. 2014; 20(4):643-8. PMC: 3966393. DOI: 10.3201/eid2004.131681. View

10.

Van Bortel W, Dorleans F, Rosine J, Blateau A, Rousset D, Matheus S . Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe. Euro Surveill. 2014; 19(13). DOI: 10.2807/1560-7917.es2014.19.13.20759. View

11.

Scholtens S, Smidt N, Swertz M, Bakker S, Dotinga A, Vonk J . Cohort Profile: LifeLines, a three-generation cohort study and biobank. Int J Epidemiol. 2014; 44(4):1172-80. DOI: 10.1093/ije/dyu229. View

12.

Mindell J, Giampaoli S, Goesswald A, Kamtsiuris P, Mann C, Mannisto S . Sample selection, recruitment and participation rates in health examination surveys in Europe--experience from seven national surveys. BMC Med Res Methodol. 2015; 15:78. PMC: 4595185. DOI: 10.1186/s12874-015-0072-4. View

13.

Swart E, van Gageldonk P, de Melker H, van der Klis F, Berbers G, Mollema L . Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study. PLoS One. 2016; 11(2):e0148605. PMC: 4749226. DOI: 10.1371/journal.pone.0148605. View

14.

Woudenberg T, van Binnendijk R, Sanders E, Wallinga J, de Melker H, Ruijs W . Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology. Euro Surveill. 2017; 22(3). PMC: 5322286. DOI: 10.2807/1560-7917.ES.2017.22.3.30443. View

15.

Torres J, Orduna T, Pina-Pozas M, Vazquez-Vega D, Sarti E . Epidemiological Characteristics of Dengue Disease in Latin America and in the Caribbean: A Systematic Review of the Literature. J Trop Med. 2017; 2017:8045435. PMC: 5368385. DOI: 10.1155/2017/8045435. View

16.

Colon-Gonzalez F, Peres C, Bernardo C, Hunter P, Lake I . After the epidemic: Zika virus projections for Latin America and the Caribbean. PLoS Negl Trop Dis. 2017; 11(11):e0006007. PMC: 5683651. DOI: 10.1371/journal.pntd.0006007. View

17.

Klompmaker J, Hoek G, Bloemsma L, Gehring U, Strak M, Wijga A . Green space definition affects associations of green space with overweight and physical activity. Environ Res. 2017; 160:531-540. DOI: 10.1016/j.envres.2017.10.027. View

18.

Knol M, Hahne S, Lucidarme J, Campbell H, de Melker H, Gray S . Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. Lancet Public Health. 2017; 2(10):e473-e482. DOI: 10.1016/S2468-2667(17)30157-3. View

19.

Desselberger U . The Mammalian Intestinal Microbiome: Composition, Interaction with the Immune System, Significance for Vaccine Efficacy, and Potential for Disease Therapy. Pathogens. 2018; 7(3). PMC: 6161280. DOI: 10.3390/pathogens7030057. View